iSpecimen Inc. (ISPC): Price and Financial Metrics


iSpecimen Inc. (ISPC): $2.89

-0.01 (-0.34%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ISPC Stock Price Chart Interactive Chart >

Price chart for ISPC

ISPC Price/Volume Stats

Current price $2.89 52-week high $28.98
Prev. close $2.90 52-week low $2.07
Day low $2.79 Volume 16,757
Day high $2.95 Avg. volume 731,589
50-day MA $3.49 Dividend yield N/A
200-day MA $6.09 Market Cap 25.48M

iSpecimen Inc. (ISPC) Company Bio


iSpecimen, Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables researchers to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.


ISPC Latest News Stream


Event/Time News Detail
Loading, please wait...

ISPC Latest Social Stream


Loading social stream, please wait...

View Full ISPC Social Stream

Latest ISPC News From Around the Web

Below are the latest news stories about iSpecimen Inc that investors may wish to consider to help them evaluate ISPC as an investment opportunity.

Quite a few insiders invested in iSpecimen Inc. (NASDAQ:ISPC) last year which is positive news for shareholders

Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...

Yahoo | February 24, 2022

Aridis, Rhythm top healthcare gainers; 10x Genomics, iSpecimen lead losers pack

Gainers: Aridis Pharmaceuticals (NASDAQ:ARDS) +12%. Rhythm Pharmaceuticals (NASDAQ:RYTM) +12%. Outset Medical (NASDAQ:OM) +10%. Masimo (NASDAQ:MASI) +8%. Vivos Therapeutics (NASDAQ:VVOS) +7%. Losers: 10x Genomics (NASDAQ:TXG) -16%. iSpecimen (NASDAQ:ISPC) -10%. Poseida Therapeutics (NASDAQ:PSTX) -8%. R1 RCM (NASDAQ:RCM) -8%. Community Health Systems (NYSE:CYH) -6%....

Seeking Alpha | February 17, 2022

iSpecimen Inc. (ISPC) CEO Christopher Ianelli on Q4 2021 Results - Earnings Call Transcript

Call Ended: 08:53 Title: iSpecimen Inc. (ISPC) Q4 2021 Earning Conference Call February 17, 2022, 8:30 AM ET Company Participants Christopher Ianelli – Chief Executive Officer and President Tracy Curley – Chief Financial Officer Jill Mullan – Chief Operating Officer Allison Soss – Investor Relations Conference Call Participants Lucas Baranowski...

SA Transcripts on Seeking Alpha | February 17, 2022

iSpecimen Reports Full Year 2021 Financial Results

Record FY 2021 Revenue of $11.1 Million, Surpassing FY 2020 Revenue of $8.2 Million by 36%LEXINGTON, Mass., Feb. 17, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online marketplace for human biospecimens, today reported its financial results for the three and twelve-month periods ended December 31, 2021. “iSpecimen achieved significant milestones in 2021. During the year, we successfully closed our IPO and began trading on the NASDAQ, raised $21 milli

Yahoo | February 17, 2022

iSpecimen to Participate in the Aegis Virtual Conference on February 24, 2022

LEXINGTON, Mass., Feb. 10, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (NASDAQ: ISPC) (“iSpecimen” or the “Company”), an online marketplace for human biospecimens, today announced that Christopher Ianelli, MD, PhD, CEO and President, will participate in the Aegis Capital Corp. Virtual Conference to be held virtually on February 23-25, 2022. Dr. Ianelli will present on Thursday, February 24, 2022 at 12:30 p.m. ET. To access the event, please download and import the following iCalendar (.ics) files to

Yahoo | February 10, 2022

Read More 'ISPC' Stories Here

ISPC Price Returns

1-mo -24.74%
3-mo -25.32%
6-mo -83.50%
1-year N/A
3-year N/A
5-year N/A
YTD -63.00%
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.639 seconds.